Diabetes-induced proteome changes throughout development
Background: Diabetes Mellitus (DM) is a multisystemic disease involving the homeostasis of
insulin secretion by the pancreatic islet beta cells (β-cells). It is associated with hypertension …
insulin secretion by the pancreatic islet beta cells (β-cells). It is associated with hypertension …
Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions
T Sparre, MR Larsen, PE Heding, AE Karlsen… - Molecular & Cellular …, 2005 - ASBMB
Type 1 diabetes (T1D) is the result of selective destruction of the insulin-producing β-cells in
the pancreatic islets of Langerhans. T1D is due to a complex interplay between the β-cell …
the pancreatic islets of Langerhans. T1D is due to a complex interplay between the β-cell …
Update on diabetes mellitus
M Korc - Disease markers, 2004 - content.iospress.com
Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune
mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 …
mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 …
Application of genomics and proteomics in Type 1 diabetes pathogenesis research
T Sparre, R Bergholdt, J Nerup… - Expert Review of …, 2003 - Taylor & Francis
Type 1 diabetes is a polygenic, multifactorial autoimmune disease characterized by
selective and irreversible destruction of the insulin-producing β-cells in the pancreatic islets …
selective and irreversible destruction of the insulin-producing β-cells in the pancreatic islets …
Liver proteome in diabetes type 1 rat model: Insulin-dependent and-independent changes
CP Braga, CHT Boone, RA Grove… - Omics: a journal of …, 2016 - liebertpub.com
Abstract Diabetes mellitus type 1 (DM1) is a major public health problem that continues to
burden the healthcare systems worldwide, costing exponentially more as the epidemic …
burden the healthcare systems worldwide, costing exponentially more as the epidemic …
Type 2 diabetes: Gaining insight into the disease process using proteomics
M Maris, L Overbergh, C Mathieu - PROTEOMICS–Clinical …, 2008 - Wiley Online Library
The incidence of diabetes mellitus is growing rapidly, with an increasing disease related
morbidity and mortality. This is caused by macro‐and microvascular complications, as a …
morbidity and mortality. This is caused by macro‐and microvascular complications, as a …
[HTML][HTML] The Human Diabetes Proteome Project (HDPP): from network biology to targets for therapies and prevention
Type 2 diabetes is a worldwide disease reaching epidemic dimensions. The rapid
progression of the disease urgently calls for both a broader and deeper understanding of its …
progression of the disease urgently calls for both a broader and deeper understanding of its …
A critical review of proteomic studies in gestational diabetes mellitus
T Zhou, L Huang, M Wang, D Chen… - Journal of Diabetes …, 2020 - Wiley Online Library
Gestational diabetes mellitus is a progressive and complex pregnancy complication, which
threatens both maternal and fetal health. It is urgent to screen for specific biomarkers for …
threatens both maternal and fetal health. It is urgent to screen for specific biomarkers for …
Application of mass spectrometry based proteomics to understand diabetes: a special focus on interactomics
Diabetes, a multifactorial disorder is characterized by elevated blood glucose levels
resulting from changes in lifestyle, genetic and epigenetic changes or aberrations in …
resulting from changes in lifestyle, genetic and epigenetic changes or aberrations in …
Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 Diabetes progression
Blood markers other than islet autoantibodies are greatly needed to indicate the pancreatic
beta cell destruction process as early as possible, and more accurately reflect the …
beta cell destruction process as early as possible, and more accurately reflect the …